Canada· CA-DIN-02288931
OXY-20 NW
A medicinal product containing oxytocin, registered in Canada by RAFTER 8 PRODUCTS INC.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- OXYTOCIN
- Manufacturer
- RAFTER 8 PRODUCTS INC
- Country
- Canada (CA)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Oxytocin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomOxytocin 10units/1ml concentrate for solution for infusion ampoulesPanpharma UK Ltd
- United StatesOxytocinCardinal Health 107, LLC
- SwedenOxygrindeks 8,3 mikrogram/ml Injektions-/infusionsvätska, lösningAS GRINDEKS
- NorwayOxytocin cd pharmaCD Pharmaceuticals
- FinlandOxytocin OrifarmOrifarm Generics A/S
- CzechiaOFOSTAS GRINDEKS, Riga
- NetherlandsOxytocine Eureco-Pharma 5 IE/ml, concentraat voor oplossing voor infusie, oplossing voor injectieEureco-Pharma B.V.
- IrelandOfost 10 IU/ml concentrate for solution for infusion or solution for intramuscular injectionAS Grindeks
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Oxytocin Grindeks, Syntocinon
- Belgium · Oxytocin Grindeks, Syntocinon
- Bulgaria · Окситоцин Pихtep
- Cyprus · Syntocinon
- Czechia · Ofost, Oxytocin Avmc
- Germany · Oxytocin Hexal, Oxytocin Panpharma
- Denmark · Oxytocin Orifarm, Syntocinon
- Estonia · Oxytocin Grindeks
- Spain · Oxitocina Grindeks, Syntocinon
- Finland · Oxytocin Orifarm, Syntocinon
- France · Oxytocine Ever Pharma, Oxytocine Grindeks
- United Kingdom (Northern Ireland) · Oxytocin, Oxytocin Hameln Pharma
- Greece · Oxytocin Gap
- Croatia · Syntocinon
- Hungary · Oxytocin Grindeks, Oxytocin Panpharma
- Ireland · Ofost, Oxytocin Pinewood Laboratories
- Iceland · Syntocinon
- Italy · Ossitocina Grindeks, Syntocinon
- Lithuania · Ofost, Oxytocin Grindeks
- Latvia · Ofost, Oxytocin Grindeks
- Malta · Oxytocin Wockhardt, Syntocinon
- Netherlands · Syntocinon
- Norway · Oxytocin Cd Pharma, Oxytocin Orifarm
- Poland · Oxytocin Grindeks, Oxytocin Grindex
- Portugal · Oxitocina Generis, Oxitocina Grindeks
- Romania · Ofost, Oxitocină Panpharma
- Sweden · Oxytocin Cd Pharma, Oxytocin Grindeks
- Slovenia · Ofost, Syntocinon
- Slovakia · Ofost, Oxygrindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e1d578b-85ea-40f7-bb49-54625fa4878c GET /v1/drugs/6e1d578b-85ea-40f7-bb49-54625fa4878c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02288931",
"form": "SOLUTION",
"class": "Veterinary",
"routes": [
"INTRAMUSCULAR",
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": null,
"schedule": [
"Prescription"
],
"drug_code": "77433",
"strengths": [
"20 UNIT"
],
"ahfs_class": null,
"substances": [
"OXYTOCIN"
],
"product_categorization": null
}See everything about oxytocin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.